BioMarin Pharmaceutical
BMRN
#1885
Rank
C$15.30 B
Marketcap
C$79.00
Share price
-0.16%
Change (1 day)
6.88%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): C$1.05

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is C$0.54. In 2022 the company made an earnings per share (EPS) of C$1.08 an increase over its 2021 EPS that were of C-$0.49.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$1.05-3.49%
2022C$1.08-319.62%
2021C-$0.49-107.38%
2020C$6.68-3485.71%
2019C-$0.20-67.44%
2018C-$0.61-34.85%
2017C-$0.93-83.21%
2016C-$5.54263.89%
2015C-$1.5218.68%
2014C-$1.28-28.91%
2013C-$1.8034.74%
2012C-$1.3493.88%
2011C-$0.69-124.5%
2010C$2.82
2009N/A-100%
2008C$0.45-300%
2007C-$0.23-54.29%
2006C-$0.49-67.89%
2005C-$1.54-62.54%
2004C-$4.10136.59%
2003C-$1.73-15.17%
2002C-$2.04-11.59%
2001C-$2.3156.19%
2000C-$1.4810.53%
1999C-$1.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.68 400.77%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
C-$8.23-1,636.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C-$0.54-200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.02820-105.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.16-128.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$2.55 376.32%๐Ÿ‡บ๐Ÿ‡ธ USA